Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR52228
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Gagne, Donald; Aramini, James; Aubin, Yves. "Assignment of trastuzumab-scFab" Biomolecular NMR Assignments ., .-. (2024).
Assembly members:
entity_1, polymer, 485 residues, Formula weight is not available
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pET15
Data type | Count |
13C chemical shifts | 1373 |
15N chemical shifts | 405 |
1H chemical shifts | 829 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | trastuzumab-scFab | 1 |
Entity 1, trastuzumab-scFab 485 residues - Formula weight is not available
1 | GLY | SER | GLU | VAL | GLN | LEU | VAL | GLU | SER | GLY | ||||
2 | GLY | GLY | LEU | VAL | GLN | PRO | GLY | GLY | SER | LEU | ||||
3 | ARG | LEU | SER | CYS | ALA | ALA | SER | GLY | PHE | ASN | ||||
4 | ILE | LYS | ASP | THR | TYR | ILE | HIS | TRP | VAL | ARG | ||||
5 | GLN | ALA | PRO | GLY | LYS | GLY | LEU | GLU | TRP | VAL | ||||
6 | ALA | ARG | ILE | TYR | PRO | THR | ASN | GLY | TYR | THR | ||||
7 | ARG | TYR | ALA | ASP | SER | VAL | LYS | GLY | ARG | PHE | ||||
8 | THR | ILE | SER | ALA | ASP | THR | SER | LYS | ASN | THR | ||||
9 | ALA | TYR | LEU | GLN | MET | ASN | SER | LEU | ARG | ALA | ||||
10 | GLU | ASP | THR | ALA | VAL | TYR | TYR | CYS | SER | ARG | ||||
11 | TRP | GLY | GLY | ASP | GLY | PHE | TYR | ALA | MET | ASP | ||||
12 | TYR | TRP | GLY | GLN | GLY | THR | LEU | VAL | THR | VAL | ||||
13 | SER | SER | ALA | SER | THR | LYS | GLY | PRO | SER | VAL | ||||
14 | PHE | PRO | LEU | ALA | PRO | SER | SER | LYS | SER | THR | ||||
15 | SER | GLY | GLY | THR | ALA | ALA | LEU | GLY | CYS | LEU | ||||
16 | VAL | LYS | ASP | TYR | PHE | PRO | GLU | PRO | VAL | THR | ||||
17 | VAL | SER | TRP | ASN | SER | GLY | ALA | LEU | THR | SER | ||||
18 | GLY | VAL | HIS | THR | PHE | PRO | ALA | VAL | LEU | GLN | ||||
19 | SER | SER | GLY | LEU | TYR | SER | LEU | SER | SER | VAL | ||||
20 | VAL | THR | VAL | PRO | SER | SER | SER | LEU | GLY | THR | ||||
21 | GLN | THR | TYR | ILE | CYS | ASN | VAL | ASN | HIS | LYS | ||||
22 | PRO | SER | ASN | THR | LYS | VAL | ASP | LYS | LYS | VAL | ||||
23 | GLU | PRO | LYS | SER | CYS | ASP | LYS | THR | HIS | THR | ||||
24 | ALA | PRO | GLY | GLY | GLY | GLY | SER | GLY | GLY | GLY | ||||
25 | GLY | SER | GLY | GLY | GLY | GLY | SER | GLY | GLY | GLY | ||||
26 | GLY | SER | GLY | GLY | GLY | GLY | SER | GLY | GLY | GLY | ||||
27 | GLY | SER | SER | SER | GLY | LEU | VAL | PRO | ARG | GLY | ||||
28 | SER | ASP | ILE | GLN | MET | THR | GLN | SER | PRO | SER | ||||
29 | SER | LEU | SER | ALA | SER | VAL | GLY | ASP | ARG | VAL | ||||
30 | THR | ILE | THR | CYS | ARG | ALA | SER | GLN | ASP | VAL | ||||
31 | ASN | THR | ALA | VAL | ALA | TRP | TYR | GLN | GLN | LYS | ||||
32 | PRO | GLY | LYS | ALA | PRO | LYS | LEU | LEU | ILE | TYR | ||||
33 | SER | ALA | SER | PHE | LEU | TYR | SER | GLY | VAL | PRO | ||||
34 | SER | ARG | PHE | SER | GLY | SER | ARG | SER | GLY | THR | ||||
35 | ASP | PHE | THR | LEU | THR | ILE | SER | SER | LEU | GLN | ||||
36 | PRO | GLU | ASP | PHE | ALA | THR | TYR | TYR | CYS | GLN | ||||
37 | GLN | HIS | TYR | THR | THR | PRO | PRO | THR | PHE | GLY | ||||
38 | GLN | GLY | THR | LYS | VAL | GLU | ILE | LYS | ARG | THR | ||||
39 | VAL | ALA | ALA | PRO | SER | VAL | PHE | ILE | PHE | PRO | ||||
40 | PRO | SER | ASP | GLU | GLN | LEU | LYS | SER | GLY | THR | ||||
41 | ALA | SER | VAL | VAL | CYS | LEU | LEU | ASN | ASN | PHE | ||||
42 | TYR | PRO | ARG | GLU | ALA | LYS | VAL | GLN | TRP | LYS | ||||
43 | VAL | ASP | ASN | ALA | LEU | GLN | SER | GLY | ASN | SER | ||||
44 | GLN | GLU | SER | VAL | THR | GLU | GLN | ASP | SER | LYS | ||||
45 | ASP | SER | THR | TYR | SER | LEU | SER | SER | THR | LEU | ||||
46 | THR | LEU | SER | LYS | ALA | ASP | TYR | GLU | LYS | HIS | ||||
47 | LYS | VAL | TYR | ALA | CYS | GLU | VAL | THR | HIS | GLN | ||||
48 | GLY | LEU | SER | SER | PRO | VAL | THR | LYS | SER | PHE | ||||
49 | ASN | ARG | GLY | GLU | CYS |
sample_1: trastuzumab-scFab, [U-100% 13C; U-100% 15N; U-100% 2H], 395 uM; Na Acetate-d3, [U-2H], 20 mM
sample_2: trastuzumab-scFab, [U-13C; U-15N; U-2H; 99% 1HD-Ile,Leu; 99% 1HG-Val], 464 uM; Na Acetate-d3, [U-2H], 20 mM
sample_3: trastuzumab-scFab, [U-10% 13C; U-100% 15N], 236 uM; Na Acetate-d3, [U-2H], 20 mM
sample_conditions_1: pH: 5.0; temperature: 313 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
3D HNCO | sample_1 | isotropic | sample_conditions_1 |
3D HN(CA)CO | sample_1 | isotropic | sample_conditions_1 |
3D HNCA | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
3D HNCACB | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CACB | sample_1 | isotropic | sample_conditions_1 |
3D CCH-TOCSY | sample_2 | isotropic | sample_conditions_1 |
3D HCCH-TOCSY | sample_2 | isotropic | sample_conditions_1 |
2D 1H-15N TROSY | sample_1 | isotropic | sample_conditions_1 |
2D 1H-13C HSQC | sample_1 | isotropic | sample_conditions_1 |
2D 1H-13C HSQC | sample_3 | isotropic | sample_conditions_1 |
TOPSPIN v3.5.7 - collection
NMRViewJ v9.2.0-b27 - chemical shift assignment, data analysis, peak picking
TOPSPIN v4.0.8 - collection
NMRPipe v11.5 - processing
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks